SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors

Zhongwu Li, Beijing Cancer Hospital
Jing Yuan, The Chinese PLA General Hospital
Lixin Wei, The Chinese PLA General Hospital
Lixin Zhou, Beijing Cancer Hospital
Kaiyong Mei, Guangzhou Medical University
Junqiu Yue, Hubei Cancer Hospital
Hongwen Gao, Jilin University
Miao Zhang, Beijing Cancer Hospital
Ling Jia, Beijing Cancer Hospital
Qiang Kang, Beijing Cancer Hospital
Xiaozheng Huang, Beijing Cancer Hospital
Dengfeng Cao, Washington University School of Medicine

Abstract